ÂÜÀòÂÒÂ×

Adam Heller is SynAgile's Chief Scientific Officer and an emeritus professor of chemistry, chemical engineering, and materials science at the University of Texas at Austin. At GTE Research, Adam and his colleague Jim Auborn conceived and codeveloped the first commercialized lithium thionyl chloride battery, a product that has sold billions of units. At AT&T Bell Labs, Adam headed the department that developed manufacturing processes for high-density chip interconnections. He cofounded TheraSense with Ephraim and served as its CTO, leading development of a product that has again sold billions of units. He holds over 200 issued US patents. Adam received his doctorate from the Hebrew University in Jerusalem and is regarded as one of the top bioelectrochemists of the world. He received numerous prestigious awards, including the 2008 US National Medal of Technology and Innovation, the top technology honor of the United States.